Blog
Featured Post
DMC vs IRB: What’s the Difference?
In a complex clinical trial, data monitoring committee's oversee interim data to ensure adequate safety monitoring.
Read moreFDA Communications Through the Drug Development Lifecycle
As a drug makes its way through the development lifecycle, one of the most important relationships for a sponsor to...
Understand how to effectively communicate and build a relationship with the FDA throughout the drug development lifecycle.
Data Integrity – It’s All About the Data!
In this increasingly digital world, we have to remember data is now available in many different medians, including paper. When we think of clinical trials and the critical data...
This blog dives into data integrity in clinical research, including how to obtain and maintain data throughout its lifecycle.
6 Tips for Creating Effective Clinical Trial Training
Consistent and effective training delivery across sites is challenging when addressing a global clinical trial with double or triple-digit site...
This blog offers practical tips for effective site training to ensure your global clinical trials are compliant and efficient.
Ensuring a Successful and Collaborative SDLC Process
At Advarra, it’s our mission to ensure safer, smarter, faster clinical research every step of the way in the research...
Find out how Advarra's approach to the SDLC lifecycle leads to successful collaborations among sites and sponsors.
4 Questions to Ask CTMS Vendors
When it comes to selecting a clinical trial management system (CTMS) for your research organization, there dozens of factors to...
Ensure your organization has the tools to both efficiently and compliantly implement remote modalities to best reap the benefits of DCT
IRB Review of Phase I Research: Balancing Ethics and Efficiency
Phase I research is a crucial part of drug and therapy development. Because it differs in important ways from later...
Find out how to address Phase I research challenges to enable efficient IRB review and timely study startup.
3 Must-Haves to Deploy Remote Clinical Trials
Decentralized clinical trials (DCTs) are becoming one of the most dynamic ways to conduct clinical research. The ability for research...
Ensure your organization has the tools to both efficiently and compliantly implement remote modalities to best reap the benefits of DCT
Understanding eSource, ePRO, and EDC
As the clinical research industry becomes more technology-centric than ever before, it’s becoming more common to work with connected technology...
eSource, ePRO, and EDC are integral to efficient clinical research. This blog explores how they work together and their differences.
Beginner’s Guide to Minimal Risk Research
When an institutional review board (IRB) determines research is “minimal risk” (as defined in Department of Health and Human Services...
How can researchers know when research is minimal risk? Learn an overview and the regulatory flexibilities that might be eligible.
Beginner’s Guide to Independent Asset Reviews
Learn more about independent asset reviews and how they can enhance research operations.
Understanding Medical Science Liaisons and Clinical Liaisons
Research organizations utilize a variety of medical professionals to conduct successful clinical trials. Two of those positions are a medical...
This blog describes the difference between medical science liaisons and clinical liaisons, and their role in clinical research.
Maintaining a Robust Clinical Trial Pipeline
The clinical research landscape is likely forever altered by the COVID-19 pandemic, especially regarding trial continuity and the potential for...
Explore how the COVID-19 pandemic has changed the clinical trial landscape and how it affects the business pipeline.
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, White Papers, Podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2021 Advarra. All Rights Reserved.